Work

Durvalumab in advanced biliary tract cancer

Year: 2026

Type: editorial

Abstract: How effective and safe is durvalumab in the treatment of advanced biliary tract cancer? Eligibility criteria• Patient: Advanced biliary tract cancer (unresectable, locally advanced, or metastatic biliary tract adenocarcinoma, including intrahepatic or extrahepatic cholangiocarcinoma and gallbladder carcinoma).• Intervention: Durvalumab, either in combination or not.

Source: Revista da Associação Médica Brasileira

DOI: 10.1590/1806-9282.2025d721

Authors: Maurício Anhesini, Antonio Silvinato, Idevaldo Floriano, Wanderley Marques Bernardo

Institutions: Brazilian Medical Association, Universidade de São Paulo

Language: Portuguese

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W7148901690

Cites: 9

Cited by:

Related to: 10